Medicine & Health

Washington University’s McDonnell International Scholars Academy and Social Policy Institute seek proposals from WashU researchers and their international partners to identify and address the challenges of COVID-19 through artificial intelligence, technology and big data. Proposals are due Feb. 26.

Researchers at Washington University School of Medicine have used light to decode brain signals and identify what image a person sees. It could be a step toward helping people who are unable to express themselves because of brain injury or disease communicate.

People now have access to better real-time information about COVID-19 infection and transmission rates, but they still have to decide what is safe to do. A new model co-authored by mathematician John McCarthy in Arts & Sciences at Washington University in St. Louis helps to contend with the uncertainty.

Researchers at Washington University School of Medicine have engineered cartilage cells to release an anti-inflammatory drug in response to stresses such cells undergo when they are compressed during weight bearing and movement.

Researchers at Washington University School of Medicine have found that immune cells stationed in such sinuses monitor the brain and initiate an immune response if they detect a problem.

A new study from Washington University School of Medicine suggests that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer.

Michael S. Kinch, associate vice chancellor and director of the Centers for Research Innovation in Biotechnology and Drug Discovery, and professor of biochemistry and molecular biophysics at the School of Medicine,, received a one-year $280,385 grant from Arnold Ventures for his research titled “CDEK: Clinical Data Experience Knowledge-base.”

Alex Holehouse, assistant professor of biochemistry and molecular biophysics at the School of Medicine, received a one-year $91,539 grant from Dewpoint Therapeutics for his research titled “Bioinformatic tools for the analysis of phase separating proteins.”

Researchers at Washington University School of Medicine have developed an imaging agent that could help refine assessments of kidney health, potentially salvaging some otherwise discarded donor kidneys.

WashU engineers have developed a biosensing microneedle patch that can be applied to the skin, capture a biomarker and, thanks to its unprecedented sensitivity, allow clinicians to detect the biomarker’s presence.